Pfizer reports $3.5 billion in quarterly sales from Covid vaccine, raises outlook

FAN Editor

A woman holds a small bottle labeled with a “Coronavirus COVID-19 Vaccine” sticker and a medical syringe in front of displayed Pfizer logo in this illustration taken, October 30, 2020.

Dado Ruvic | Reuters

Pfizer on Tuesday reported $3.5 billion in first-quarter sales of its Covid-19 vaccine with German drugmaker BioNTech.

In releasing its first-quarter financial results, the company also reported earnings and revenue that beat Wall Street’s expectations.

Here’s how Pfizer did compared with what Wall Street expected, according to average estimates compiled by Refinitiv:

  • Adjusted EPS: 93 cents per share vs 77 cents expected
  • Revenue: $14.58 billion vs. $13.51 billion expected

CNBC Health & Science

This is a developing story. Please check back for updates.

Free America Network Articles

Leave a Reply

Next Post

CVS Health earnings top estimates as Covid vaccinations, testing boost drugstore sales

People walk by a CVS Pharmacy store in the Manhattan borough of New York City. Shannon Stapleton | Reuters CVS Health reported a strong first quarter and raised its full-year forecast, as customers came to its stores for Covid-19 vaccinations, tests and prescriptions. The company has been a major provider […]